These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia]. Popov AM, Verzhbitskaia TIu, Tsaur GA, Shorikov EV, Savel'ev LI, Tsvirenko SV, Fechina LG. Klin Lab Diagn; 2010 Aug 21; (8):36-41. PubMed ID: 20886718 [Abstract] [Full Text] [Related]
3. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis. Rothe G, Schmitz G. Leukemia; 1996 May 21; 10(5):877-95. PubMed ID: 8656686 [Abstract] [Full Text] [Related]
4. Flow cytometric monitoring of residual disease in acute leukemia. Wood BL. Methods Mol Biol; 2013 May 21; 999():123-36. PubMed ID: 23666694 [Abstract] [Full Text] [Related]
5. [Contribution of immunotyping in the diagnosis and in the prognosis of acute leukemia]. Merle-Béral H, Boucheix C. Rev Prat; 1996 Jan 01; 46(1):30-6. PubMed ID: 8596888 [Abstract] [Full Text] [Related]
6. Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease. Huh YO, Ibrahim S. Hematol Oncol Clin North Am; 2000 Dec 01; 14(6):1251-65. PubMed ID: 11147222 [Abstract] [Full Text] [Related]
7. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia. Babusíková O, Glasová M, Koníková E, Kusenda J. Neoplasma; 1996 Dec 01; 43(6):367-72. PubMed ID: 8996560 [Abstract] [Full Text] [Related]
8. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease. Drach J, Drach D, Glassl H, Gattringer C, Huber H. Cytometry; 1992 Dec 01; 13(8):893-901. PubMed ID: 1459006 [Abstract] [Full Text] [Related]
9. Minimally differentiated acute myeloid leukemia (AML-MO) with lymphoid presentation at relapse: a case report. Ysebaert L, Carli PM, Casasnovas RO, Girodon F, Caillot D, Mugneret F, Maynadié M. Leukemia; 2001 Oct 01; 15(10):1673-4. PubMed ID: 11587233 [No Abstract] [Full Text] [Related]
10. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia. Zelezníková T, Babusíková O. Neoplasma; 2006 Oct 01; 53(6):500-6. PubMed ID: 17167719 [Abstract] [Full Text] [Related]
11. Immunophenotypic analysis of acute lymphocytic leukemia. Riley RS, Massey D, Jackson-Cook C, Idowu M, Romagnoli G. Hematol Oncol Clin North Am; 2002 Apr 01; 16(2):245-99, v. PubMed ID: 12094473 [Abstract] [Full Text] [Related]
13. Immunophenotyping of acute leukemia by flow cytometry: closing the black holes of morphology. Santos EC, Castro-e-Melo JV. Bull Cancer; 1995 Jan 01; 82(2):117-21. PubMed ID: 10846528 [Abstract] [Full Text] [Related]
14. Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia. Campana D, Coustan-Smith E. Best Pract Res Clin Haematol; 2002 Mar 01; 15(1):1-19. PubMed ID: 11987913 [Abstract] [Full Text] [Related]
15. First proposed panels on acute leukemia for four-color immunophenotyping by flow cytometry from the Brazilian group of flow cytometry-GBCFLUX. Ikoma MR, Sandes AF, Thiago LS, Cavalcanti Júnior GB, Lorand-Metze IG, Costa ES, Pimenta G, Santos-Silva MC, Bacal NS, Yamamoto M, Souto EX, GBCFLUX. Cytometry B Clin Cytom; 2015 Mar 01; 88(3):194-203. PubMed ID: 24753208 [Abstract] [Full Text] [Related]
19. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia. Paredes-Aguilera R, Romero-Guzman L, Lopez-Santiago N, Burbano-Ceron L, Camacho-Del Monte O, Nieto-Martinez S. Am J Hematol; 2001 Oct 01; 68(2):69-74. PubMed ID: 11559944 [Abstract] [Full Text] [Related]
20. Immunophenotyping of acute leukemia: utility of CD45 for blast cell identification. Vial JP, Lacombe F. Methods Cell Biol; 2001 Oct 01; 64():343-58. PubMed ID: 11070847 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]